178 related articles for article (PubMed ID: 37707822)
1. Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial.
Swisher EM; Rayes N; Bowen D; Peterson CB; Norquist BM; Coffin T; Gavin K; Polinsky D; Crase J; Bakkum-Gamez JN; Blank SV; Munsell MF; Nebgen D; Fleming GF; Olopade OI; Law S; Zhou A; Levine DA; D'Andrea A; Lu KH
JAMA Oncol; 2023 Nov; 9(11):1547-1555. PubMed ID: 37707822
[TBL] [Abstract][Full Text] [Related]
2. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
[TBL] [Abstract][Full Text] [Related]
3. Web Platform vs In-Person Genetic Counselor for Return of Carrier Results From Exome Sequencing: A Randomized Clinical Trial.
Biesecker BB; Lewis KL; Umstead KL; Johnston JJ; Turbitt E; Fishler KP; Patton JH; Miller IM; Heidlebaugh AR; Biesecker LG
JAMA Intern Med; 2018 Mar; 178(3):338-346. PubMed ID: 29356820
[TBL] [Abstract][Full Text] [Related]
4. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
[TBL] [Abstract][Full Text] [Related]
5. Evaluating an Innovative HIV Self-Testing Service With Web-Based, Real-Time Counseling Provided by an Artificial Intelligence Chatbot (HIVST-Chatbot) in Increasing HIV Self-Testing Use Among Chinese Men Who Have Sex With Men: Protocol for a Noninferiority Randomized Controlled Trial.
Chen S; Zhang Q; Chan CK; Yu FY; Chidgey A; Fang Y; Mo PKH; Wang Z
JMIR Res Protoc; 2023 Jun; 12():e48447. PubMed ID: 37389935
[TBL] [Abstract][Full Text] [Related]
6. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
[TBL] [Abstract][Full Text] [Related]
7. TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.
Loeb S; Keith SW; Cheng HH; Leader AE; Gross L; Sanchez Nolasco T; Byrne N; Hartman R; Brown LH; Pieczonka CM; Gomella LG; Kelly WK; Lallas CD; Handley N; Mille PJ; Mark JR; Brown GA; Chopra S; McClellan A; Wise DR; Hollifield L; Giri VN
JCO Precis Oncol; 2024 Mar; 8():e2300552. PubMed ID: 38452310
[TBL] [Abstract][Full Text] [Related]
8. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of a Randomized Controlled Trial of Genomic Counseling for Patients Receiving Personalized and Actionable Complex Disease Reports.
Sweet K; Sturm AC; Schmidlen T; McElroy J; Scheinfeldt L; Manickam K; Gordon ES; Hovick S; Scott Roberts J; Toland AE; Christman M
J Genet Couns; 2017 Oct; 26(5):980-998. PubMed ID: 28345121
[TBL] [Abstract][Full Text] [Related]
12. Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.
Loeb S; Cheng HH; Leader A; Gross L; Nolasco TS; Byrne N; Wise DR; Hollifield L; Brown LH; Slater E; Pieczonka C; Gomella LG; Kelly WK; Trabulsi EJ; Handley N; Lallas CD; Chandrasekar T; Mille P; Mann M; Mark JR; Brown G; Chopra S; Wasserman J; Phillips J; Somers P; Giri VN
Contemp Clin Trials; 2022 Aug; 119():106821. PubMed ID: 35710085
[TBL] [Abstract][Full Text] [Related]
13. Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?
Audrain J; Rimer B; Cella D; Garber J; Peshkin BN; Ellis J; Schildkraut J; Stefanek M; Vogel V; Lerman C
J Clin Oncol; 1998 Jan; 16(1):133-8. PubMed ID: 9440734
[TBL] [Abstract][Full Text] [Related]
14. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Armstrong K; Micco E; Carney A; Stopfer J; Putt M
JAMA; 2005 Apr; 293(14):1729-36. PubMed ID: 15827311
[TBL] [Abstract][Full Text] [Related]
16. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Kinney AY; Butler KM; Schwartz MD; Mandelblatt JS; Boucher KM; Pappas LM; Gammon A; Kohlmann W; Edwards SL; Stroup AM; Buys SS; Flores KG; Campo RA
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376862
[TBL] [Abstract][Full Text] [Related]
17. Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study.
McCuaig JM; Tone AA; Maganti M; Romagnuolo T; Ricker N; Shuldiner J; Rodin G; Stockley T; Kim RH; Bernardini MQ
Gynecol Oncol; 2019 Apr; 153(1):108-115. PubMed ID: 30638766
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of a standardized questionnaire in facilitating personalized communication about problems encountered in cancer genetic counseling: design of a randomized controlled trial.
Eijzenga W; Aaronson NK; Kluijt I; Sidharta GN; Hahn DE; Ausems MG; Bleiker EM
BMC Cancer; 2014 Jan; 14():26. PubMed ID: 24428912
[TBL] [Abstract][Full Text] [Related]
19. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
[TBL] [Abstract][Full Text] [Related]
20. Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.
Kinney AY; Steffen LE; Brumbach BH; Kohlmann W; Du R; Lee JH; Gammon A; Butler K; Buys SS; Stroup AM; Campo RA; Flores KG; Mandelblatt JS; Schwartz MD
J Clin Oncol; 2016 Aug; 34(24):2914-24. PubMed ID: 27325848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
